Rankings
▼
Calendar
KLRS FY 2019 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$180M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$165,000
-85.5% YoY
Gross Profit
$0
0.0% margin
Operating Income
-$27M
-16182.4% margin
Net Income
-$24M
-14447.9% margin
EPS (Diluted)
$-8.42
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$139M
Total Liabilities
$18M
Stockholders' Equity
$122M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$165,000
$1M
-85.5%
Gross Profit
$0
$0
—
Operating Income
-$27M
-$4M
-642.5%
Net Income
-$24M
-$2M
-881.0%
← FY 2018
All Quarters
Q1 2019 →